Swiss-Chinese Life Sciences Forum 2018
“Chinese Pharma Goes Global”
The Chinese Pharma industry is rapidly upgrading its capabilities, moving from being a supplier of basic molecules and generics to becoming a major force in the development of innovative, molecular-targeted treatments and gene-based therapies. The Swiss Chinese Life Sciences Forum 2018 organised by BaselArea.swiss, the Fachhochschule Nordwestschweiz and the Swiss Chinese Chamber of Commerce and hosted by Novartis offers insights into key players in the Chinese Pharma landscape and identifies opportunities for greater collaboration between Swiss and Chinese Pharma.
Event Programme and Presentations:
Welcome |
Matthias Leuenberger, Country President Switzerland, Novartis / Thomas Christ, Acting President SCCC |
Novartis Shanghai Campus Live Transmission | Live Stream / Dr. Amber Cai, Head of NIBR Shanghai Operations, Scientific and Business Operations, Novartis China |
Keynote 1 – "China's healthcare market: recent trends in deal making, financing and partnering." | Guillaume Vignon, Senior Vice President Business Development at BeiGene |
Keynote 2 – "Luye Pharma Group’s Internationalization: Strategy and Experiences." | Bruno Delie, General Manager Luye Supply AG Switzerland |
Keynote 3 – "Regulatory reform in China: How to rapidly bring innovative drugs to market." |
Dr. Ruyi He, Chief Scientist at the Center for Drug Evaluation at the China Food and Drug Administration (CFDA) |
Keynote 4 - "Going East – China as the frontier for new Innovation" | Nigel Sheail, Global Head M&A and BD&L, Novartis International AG |
Keynote 5 – Swiss-Chinese Pharma Deal: Challenges and Learnings | Martin Rohrbach, Partner, Head of Life Sciences, KPMG Switzerland |
Panel discussion – "Successful partnerships between Chinese and European pharma companies: Opportunities and challenges in Licensing and M&A" | Keynote speakers + Michael Frizberg, CEO, CMAB International; Moderation Patrik Frei, CEO, Venture Valuation |
Closing summary & thanks |
|
BaselArea.swiss is the office for promoting innovation and inward investment for the cantons of Basel-Stadt, Basel-Landschaft and Jura. The core function of BaselArea.swiss is to promote the strengths of the Basel region and to support both Swiss and foreign entrepreneurs and companies in the implementation of their innovation and business projects in the region. Through its comprehensive information platform, monthly Innovation Reports and more than 80 Innovation Events annually, Baselarea.swiss contributes to the sustainable positioning of the Basel region as a leading centre for innovation and business.
|
||
---|---|---|---|
|
The University of Applied Sciences and Arts Northwestern Switzerland has over 12,000 students and 2800 employees in its nine schools in the disciplines of Applied Psychology; Architecture, Civil Engineering and Geomatics; Art and Design; Business; Education; Engineering; Life Sciences; Music; and Social Work. Its applied concept, its innovative research and its global network make the FHNW a diverse educational institution, a sought-after partner in industry and an attractive employer in Northwestern Switzerland.
|
||
|
The Swiss-Chinese Chamber of Commerce (SCCC) is a facilitator of sustainable economic relationships between Switzerland and the People’s Republic of China. The Chamber helps to establish and develop successful business interactions between Swiss and Chinese companies.
|